These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 34299246

  • 1. The Role of microRNAs in Cholangiocarcinoma.
    Shi T, Morishita A, Kobara H, Masaki T.
    Int J Mol Sci; 2021 Jul 16; 22(14):. PubMed ID: 34299246
    [Abstract] [Full Text] [Related]

  • 2. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X, Xia M, Chen D, Wu F, Lv Z, Zhan Q, Jiao Y, Wang W, Chen G, An F.
    Tumour Biol; 2016 Nov 16; 37(11):15019-15029. PubMed ID: 27658773
    [Abstract] [Full Text] [Related]

  • 3. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes.
    Kitdumrongthum S, Metheetrairut C, Charoensawan V, Ounjai P, Janpipatkul K, Panvongsa W, Weerachayaphorn J, Piyachaturawat P, Chairoungdua A.
    Life Sci; 2018 Oct 01; 210():65-75. PubMed ID: 30165035
    [Abstract] [Full Text] [Related]

  • 4. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.
    Puik JR, Meijer LL, Le Large TY, Prado MM, Frampton AE, Kazemier G, Giovannetti E.
    Pharmacogenomics; 2017 Sep 01; 18(14):1343-1358. PubMed ID: 28832247
    [Abstract] [Full Text] [Related]

  • 5. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J, Sun L, Li J, Zhou C, Cheng L, Chen K, Yan B, Qian W, Ma Q, Duan W.
    Oncol Rep; 2018 Sep 01; 40(3):1422-1434. PubMed ID: 29956786
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R, Chen Y, Tang C, Li H, Wang B, Yan Q, Hu J, Zou S.
    BMC Cancer; 2014 Dec 05; 14():917. PubMed ID: 25479763
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic significance of microRNA-203 in cholangiocarcinoma.
    Li J, Gao B, Huang Z, Duan T, Li D, Zhang S, Zhao Y, Liu L, Wang Q, Chen Z, Cheng K.
    Int J Clin Exp Pathol; 2015 Dec 05; 8(8):9512-6. PubMed ID: 26464713
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
    Qin W, Kang P, Xu Y, Leng K, Li Z, Huang L, Gao J, Cui Y, Zhong X.
    Sci Rep; 2018 Aug 15; 8(1):12176. PubMed ID: 30111807
    [Abstract] [Full Text] [Related]

  • 13. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition.
    Xu Y, Yao Y, Qin W, Zhong X, Jiang X, Cui Y.
    Biomed Pharmacother; 2018 Mar 15; 99():121-127. PubMed ID: 29329034
    [Abstract] [Full Text] [Related]

  • 14. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z, Ma J.
    Cancer Biomark; 2019 Mar 15; 24(2):173-181. PubMed ID: 30594918
    [Abstract] [Full Text] [Related]

  • 15. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
    Utispan K, Thuwajit P, Abiko Y, Charngkaew K, Paupairoj A, Chau-in S, Thuwajit C.
    Mol Cancer; 2010 Jan 24; 9():13. PubMed ID: 20096135
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma.
    Hu ZG, Zheng CW, Su HZ, Zeng YL, Lin CJ, Guo ZY, Zhong FD, Yuan GD, He SQ.
    J Cell Biochem; 2019 Jun 24; 120(6):9964-9978. PubMed ID: 30582202
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells.
    Okamoto K, Miyoshi K, Murawaki Y.
    PLoS One; 2013 Jun 24; 8(10):e77623. PubMed ID: 24147037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.